52 min listen
Ready for Prime Time? Determining the Current and Future Role of PARP Inhibitor-Based Combinations in the Management of Prostate Cancer — A Clinical I…
Ready for Prime Time? Determining the Current and Future Role of PARP Inhibitor-Based Combinations in the Management of Prostate Cancer — A Clinical I…
ratings:
Length:
169 minutes
Released:
Aug 11, 2023
Format:
Podcast episode
Description
Drs Neeraj Agarwal, Emmanuel Antonarakis, Karim Fizazi and Susan Slovin discuss the current and future role of PARP inhibitors in the management of prostate cancer.
CME information and select publications here (https://www.researchtopractice.com/PARPProstateThinkTank2023).
CME information and select publications here (https://www.researchtopractice.com/PARPProstateThinkTank2023).
Released:
Aug 11, 2023
Format:
Podcast episode
Titles in the series (100)
Current and Future Role of Immune Checkpoint Inhibitors and Other Novel Therapies in Urothelial Bladder Cancer with Dr Ashish Kamat: Featuring a discussion on recent clinical trial data on the use of immune checkpoint inhibitors and other novel therapies in the management of urothelial bladder cancer with Dr Ashish Kamat, moderated by Neil Love, MD. by Oncology Today with Dr Neil Love